Abstracts tagged "consults and patient-reported outcome measures"

Abstract Number: 928 • 2017 ACR/ARHP Annual Meeting
Online Consultation for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool: A Study of Medical Economics
Fei Xiao¹, Rui Wu², Zhenchun Zhang³, Weiqi Min⁴, Yanchun Tang⁵, Xinwang Duan⁶, Lingfei Mo⁷, Zhaojun Guo⁸, Yanping Zhao⁹, Henglian Wu¹⁰, Xia Xu¹¹, Feng Jiang¹², Jing Yu¹³, Jianhong Qiang¹⁴, Yan Wang⁹, Ruijie Wu¹⁵, Anbing Zhang¹⁶, Limei Gu¹⁷, Hui Xiao¹, Yuhua Jia¹, Yuan Liu¹, Bing Wu¹, Chunhui Shi¹ and Fengchun Zhang¹⁸, ¹Gothic Internet Technology Corporation, Shanghai, China, ²The First Affiliated Hospital of Nanchang University, Nanchang, China, ³People's Hospital of Linyi, Shandong, Linyi, China, ⁴Heze Municiple Hospital, Heze, China, ⁵Yantai YuHuangDing Hospital, Yantai, China, ⁶Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, ⁷The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China, ⁸The First People's Hospital of Huainan City, Huainan, China, ⁹First Affiliated Hospital of Harbin Medical University, Harbin, China, ¹⁰Dongguan Donghua Hospital, Dongguan, China, ¹¹Changhai Hospital, Shanghai, China, ¹²Huzhou Third People's Hospital, Huzhou, China, ¹³The First Hospital Affiliated with the University of Traditional Chinese Medicine in Liaoning Province, Shenyang, China, ¹⁴Yan'an People's Hospital, Yan'an, China, ¹⁵The Second Affiliated Hospital of Shanxi Medical College, Taiyuan, China, ¹⁶Xiangyang Central Hospital, Xiangyang, China, ¹⁷Central People's Hospital of Siping, Siping, China, ¹⁸Peking Union Medical College Hospital, Beijing, China
Background/Purpose: China doesn’t have efficient primary medical care and referral system. Patients can choose any hospitals or any doctors they like to seek medical care.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].